Works by Tormo, Mar
Results: 80
Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00835-5
- By:
- Publication type:
- Article
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00839-1
- By:
- Publication type:
- Article
ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S270, doi. 10.1016/S2152-2650(21)01655-4
- By:
- Publication type:
- Article
Poster: ALL-154: t(1;19)(q23;p13) TCF3-PBX1 May Not Be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated With MRD-Oriented Protocols from the PETHEMA Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S207, doi. 10.1016/S2152-2650(21)01295-7
- By:
- Publication type:
- Article
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 4, p. 590, doi. 10.1111/j.1365-2141.2006.06469.x
- By:
- Publication type:
- Article
Impact of clinical features, cytogenetics, genetic mutations, and methylation dynamics of CDKN2B and DLC-1 promoters on treatment response to azacitidine.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Genomic characterization in triple-negative primary myelofibrosis and other myeloid neoplasms with bone marrow fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Assessment of late cardiomyopathy by magnetic resonance imaging in patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and idarubicin.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Simultaneous analysis of the expression of 14 genes with individual prognostic value in myelodysplastic syndrome patients at diagnosis: WT1 detection in peripheral blood adversely affects survival.
- Published in:
- Annals of Hematology, 2012, v. 91, n. 12, p. 1887, doi. 10.1007/s00277-012-1538-7
- By:
- Publication type:
- Article
SARS-CoV-2 vaccine response and rate of breakthrough infection in patients with hematological disorders.
- Published in:
- Journal of Hematology & Oncology, 2022, v. 15, n. 1, p. 1, doi. 10.1186/s13045-022-01275-7
- By:
- Publication type:
- Article
A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 7, p. 2317, doi. 10.1002/cam4.2814
- By:
- Publication type:
- Article
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high‐risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real‐world comparison.
- Published in:
- Mycoses, 2018, v. 61, n. 3, p. 206, doi. 10.1111/myc.12728
- By:
- Publication type:
- Article
Peripheral T-cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome.
- Published in:
- European Journal of Haematology, 2003, v. 71, n. 4, p. 303, doi. 10.1034/j.1600-0609.2003.00051.x
- By:
- Publication type:
- Article
Darbepoetin α for the treatment of anemia in patients with myelodysplastic syndromes.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 12, p. 2807, doi. 10.1002/cncr.22343
- By:
- Publication type:
- Article
The poor prognosis of low hypodiploidy in adults with B‐cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients.
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 2, p. 263, doi. 10.1111/bjh.15887
- By:
- Publication type:
- Article
The presence of genomic imbalances is associated with poor outcome in patients with burkitt lymphoma treated with dose-intensive chemotherapy including rituximab.
- Published in:
- British Journal of Haematology, 2016, v. 172, n. 3, p. 428, doi. 10.1111/bjh.13849
- By:
- Publication type:
- Article
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.
- Published in:
- British Journal of Haematology, 2014, v. 166, n. 2, p. 189, doi. 10.1111/bjh.12876
- By:
- Publication type:
- Article
Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 4, p. 485, doi. 10.1111/bjh.12043
- By:
- Publication type:
- Article
Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 4, p. 529, doi. 10.1002/hon.2910
- By:
- Publication type:
- Article
Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1054458
- By:
- Publication type:
- Article
A phase 3 trial of azacitidine versus a semi‐intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2021, v. 127, n. 12, p. 2003, doi. 10.1002/cncr.33403
- By:
- Publication type:
- Article
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 24, p. 3958, doi. 10.1002/cncr.28950
- By:
- Publication type:
- Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status: Final results of a phase 2 study (Burkimab)
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Dose-intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 9, p. 1660, doi. 10.1002/cncr.27918
- By:
- Publication type:
- Article
A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 2, p. 410, doi. 10.1002/cncr.26273
- By:
- Publication type:
- Article
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 1, p. 127, doi. 10.1002/cncr.26279
- By:
- Publication type:
- Article
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis.
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1385987
- By:
- Publication type:
- Article
Incidence and clinical correlates of NFE2 mutations in myeloid neoplasms.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 2, p. 733, doi. 10.1111/bjh.19579
- By:
- Publication type:
- Article
Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 4, p. 1529, doi. 10.1111/bjh.19341
- By:
- Publication type:
- Article
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 6, p. 1239, doi. 10.1111/bjh.18815
- By:
- Publication type:
- Article
Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3‐PBX1 treated with measurable residual disease‐oriented protocols.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 3, p. 670, doi. 10.1111/bjh.17844
- By:
- Publication type:
- Article
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. 52, doi. 10.1111/bjh.16857
- By:
- Publication type:
- Article
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 9, p. E534, doi. 10.1002/ajh.24813
- By:
- Publication type:
- Article
Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 7, p. 614, doi. 10.1002/ajh.24732
- By:
- Publication type:
- Article
Excess mortality in the myelodysplastic syndromes.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 2, p. 149, doi. 10.1002/ajh.24606
- By:
- Publication type:
- Article
5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 6, p. 755, doi. 10.1111/ejh.13862
- By:
- Publication type:
- Article
Acute myeloid leukemia with inv(3)(q21.3q26.2)/t(3;3)(q21.3;q26.2): Study of 61 patients treated with intensive protocols.
- Published in:
- European Journal of Haematology, 2020, v. 105, n. 2, p. 138, doi. 10.1111/ejh.13417
- By:
- Publication type:
- Article
Characteristics and outcome of adult patients with acute promyelocytic leukemia and increased body mass index treated with the PETHEMA Protocols.
- Published in:
- European Journal of Haematology, 2020, v. 104, n. 3, p. 162, doi. 10.1111/ejh.13346
- By:
- Publication type:
- Article
Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials.
- Published in:
- European Journal of Haematology, 2019, v. 102, n. 1, p. 79, doi. 10.1111/ejh.13178
- By:
- Publication type:
- Article
Core binding factor acute myeloid leukemia: the impact of age, leukocyte count, molecular findings, and minimal residual disease.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 3, p. 209, doi. 10.1111/ejh.12130
- By:
- Publication type:
- Article
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
- Published in:
- European Journal of Haematology, 2007, v. 78, n. 2, p. 102, doi. 10.1111/j.1600-0609.2006.00778.x
- By:
- Publication type:
- Article
Evaluation of the outcomes of newly diagnosed patients with high-risk myelodysplastic syndrome according to the initial therapeutical strategies chosen in usual clinical practice.
- Published in:
- Leukemia & Lymphoma, 2023, v. 64, n. 3, p. 679, doi. 10.1080/10428194.2022.2154604
- By:
- Publication type:
- Article
Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
- Published in:
- Leukemia & Lymphoma, 2022, v. 63, n. 3, p. 538, doi. 10.1080/10428194.2021.1992619
- By:
- Publication type:
- Article